39
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Intestinal REG3 Lectins Protect Against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Approximately half of all deaths from liver cirrhosis, the 10 th leading cause of mortality in the United States, are related to alcohol use. Chronic alcohol consumption is accompanied by intestinal dysbiosis and bacterial overgrowth, yet little is known about the factors that alter the microbial composition or their contribution to liver disease. We previously associated chronic alcohol consumption with lower intestinal levels of the antimicrobial-regenerating islet-derived (REG)-3 lectins. Here, we demonstrate that intestinal deficiency in REG3B or REG3G increases numbers of mucosa-associated bacteria and enhances bacterial translocation to the mesenteric lymph nodes and liver, promoting the progression of ethanol-induced fatty liver disease toward steatohepatitis. Overexpression of Reg3g in intestinal epithelial cells restricts bacterial colonization of mucosal surfaces, reduces bacterial translocation, and protects mice from alcohol-induced steatohepatitis. Thus, alcohol appears to impair control of the mucosa-associated microbiota, and subsequent breach of the mucosal barrier facilitates progression of alcoholic liver disease.

          Related collections

          Author and article information

          Journal
          101302316
          33345
          Cell Host Microbe
          Cell Host Microbe
          Cell host & microbe
          1931-3128
          1934-6069
          28 February 2016
          10 February 2016
          10 February 2017
          : 19
          : 2
          : 227-239
          Affiliations
          [1 ]Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA
          [2 ]Department of Medicine, VA San Diego Healthcare System, San Diego, CA 92161, USA
          [3 ]J. Craig Venter Institute, Rockville, MD 20850, USA
          [4 ]St. Luc University Hospital, Université Catholique de Louvain, Brussels B-1200, Belgium
          [5 ]Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
          [6 ]Department of Immunology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
          Author notes
          Contact: Bernd Schnabl, M.D., Department of Medicine, University of California San Diego, MC0063, 9500 Gilman Drive, La Jolla, CA 92093, Phone 858-822-5311, Fax 858-822-5370, beschnabl@ 123456ucsd.edu
          Article
          PMC4786170 PMC4786170 4786170 nihpa754286
          10.1016/j.chom.2016.01.003
          4786170
          26867181
          d1282eac-c70d-4af7-928d-7b98362852ad
          History
          Categories
          Article

          Comments

          Comment on this article